Back to all studies
RecruitingNCT06788249

Pilot Study: Establishing Glutamatergic Changes in Rapid Antidepressant Effects of Ketamine

This study is recruiting. It focuses on depression and currently lists participation information in the United States.

DepressionOtherFrom 25 Years to 65 Years
In plain English

Key information made simple

This study is looking at whether Ketamine only can help people with depression. Participants take part in the program and complete follow-up questionnaires or assessments. Taking part may give some people access to Ketamine only, but direct benefit is not guaranteed.

What to expect

Your next step

The official record suggests a remote format run through a hospital. Participation appears to involve questionnaires, interviews, or regular check-ins about day-to-day experience. The main fit is usually being able to understand the study and consent and meeting the main study requirements, while common reasons not to take part include active substance or alcohol problems that could affect the results and pregnancy or breastfeeding. This is an early-stage study, which usually means a smaller group and a focus on learning how the approach behaves.

Public study data

Key study information

Condition
Major Depressive Disorder (MDD)
Study status
Recruiting
Sponsor / lead affiliation
University of Pennsylvania
Location / country
United States
Registry
ClinicalTrials.gov
Why this study may matter

Why this study may matter

This study may matter because it adds public evidence around depression. HopeStage presents it as a starting point for understanding the study, checking the official source, and preparing questions with a care team.

Before joining

Questions to ask before joining

Official source

Registry reference

This page links back to the public source record so people can verify details directly with the registry and research team.

If you want the full study description, eligibility criteria, locations, and sponsor information in the original format, this is the place to check before taking the next step.

Open source record
Need help deciding?

Ask HopeStage to review this study with me

This form records your interest so HopeStage can follow up with practical guidance. It is not a medical eligibility decision and it does not guarantee a study spot.

Loading the security check...
Study reference: NCT06788249. We only ask for your email here. HopeStage can help you review the study, but this is not a medical eligibility decision.
In practice

For you

Taking part may help improve understanding of your condition.

It requires regular follow-up, often through questionnaires or interviews.

Can be done remotely.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

Study clarity

Things to check before joining

Sponsor
University of Pennsylvania
Sponsor type
University
Main activity
behavioral or lifestyle intervention
Intervention
Not available
Time commitment
multiple visits or assessments
Study phase
Not available
Enrollment
Not available
Recruitment status
Recruiting
Source
Official registry link
FAQ

Questions about this study

What is Pilot Study: Establishing Glutamatergic Changes in Rapid Antidepressant Effects of Ketamine?

This study is exploring behavioral or lifestyle intervention for people with depression. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed.

Who is behind this study, and what type of sponsor is it?

This study is sponsored by University of Pennsylvania. Based on the sponsor name or official registry information, it appears to be a university. You should verify the details in the official registry record.

What does participation involve, what phase is it, and what should I ask about safety?

This study may involve behavioral or lifestyle intervention, study visits, and assessments. The time commitment is multiple visits or assessments. The study phase is not available in HopeStage data. Check the official source record to see whether a phase is listed. Enrollment is not available in HopeStage data. HopeStage cannot say whether a study is safe or right for you. Before joining, ask the research team about possible risks, time commitment, visits, side effects, compensation, safety monitoring, and whether participation may affect your current care.

Where can I verify the study details?

Use the official source record linked on this page to check the full study description, recruitment status, eligibility criteria, locations, sponsor information, phase, enrollment, contact details, and any listed risks or requirements.

Pilot Study: Establishing Glutamatergic Changes in. — Depression Clinical Trial | HopeStage